XML 15 R4.htm IDEA: XBRL DOCUMENT v3.25.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Income Statement [Abstract]        
Net sales $ 6,696,187 $ 639,893 $ 24,642,728
Cost of goods sold 9,694,096 432,634 24,545,534
Gross profit (2,997,909) 207,259 97,194
Operating expenses:        
Selling and marketing 2,073,636 66,171 9,386,157
General and administrative 625,067 963,108 2,210,097 3,460,092
Research and development 687,076 113,294 3,358,276
Vendor liability forgiveness, net of asset transfers 2,200,929
Total operating expenses 625,067 3,723,820 4,590,491 16,204,525
Operating loss (625,067) (6,721,729) (4,383,232) (16,107,331)
Other income (expense):        
Interest income (expense), net (99,084) 82 (356,644)
Total other income (expense) (99,084) 82 (356,644)
Loss before income taxes (625,067) (6,820,813) (4,383,150) (16,463,974)
Income tax expense (benefit) (525) (11,216) 24,451
Net loss $ (625,067) $ (6,820,287) $ (4,371,934) $ (16,488,425)
Net loss per share:        
Net loss per share, Basic $ (0.21) $ (3.61) $ (1.47) $ (8.74)
Net loss per share, Diluted $ (0.21) $ (3.61) $ (1.47) $ (8.74)
Basic weighted average common and common equivalent shares 3,022,805 1,890,933 2,972,118 1,886,465
Diluted weighted average common and common equivalent shares 3,022,805 1,890,933 2,972,118 1,886,465